aminoimidazole carboxamide has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giri, S; Nath, N; Prasad, R; Salem, ML; Singh, AK; Singh, I | 1 |
1 other study(ies) available for aminoimidazole carboxamide and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antigen Presentation; Cytokines; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Enzyme Activation; Female; GATA3 Transcription Factor; Glycoproteins; Humans; Immunologic Factors; Interleukin-10; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Multiple Sclerosis; Myelin Proteolipid Protein; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Protein Serine-Threonine Kinases; Ribonucleotides; T-Box Domain Proteins; Th1 Cells; Th2 Cells; Trans-Activators; Transcription Factors | 2005 |